# BioAlliance Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioalliance-pharma

- Industry: Biotechnology
- Headquarters: Paris, France
- Website: www.bioalliancepharma.com
- Total disclosed funding: $15M
- Latest round: Series C (Aug 30, 2004)
- Investors on record: 6

## About

BioAlliance Pharma is a biopharmaceutical company. It provides cancer and supportive care treatment with a focus on resistance targeting and orphan products.

## Funding rounds

- Series C, Aug 30, 2004, $15M — Auriga Partners, Capricorn Partners, Siparex, Seventure Partners, Abenex, ING Group

## Investors

- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series C
- Capricorn Partners (https://capitalatlas.ai/funds/capricorn-partners) — Series C
- Siparex (https://capitalatlas.ai/funds/siparex) — Series C
- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Series C
- Abenex (https://capitalatlas.ai/funds/abenex) — Series C
- ING Group — Series C